- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: 2006-006529-25.
Displaying page 1 of 1.
EudraCT Number: 2006-006529-25 | Sponsor Protocol Number: P05063 | Start Date*: 2007-02-22 | |||||||||||
Sponsor Name:Schering-Plough Research Institute | |||||||||||||
Full Title: Long-Term Follow-Up of Subjects in a Phase 2 or 3 Clinical Trial in which SCH 503034 was Administered for the Treatment of Chronic Hepatitis C | |||||||||||||
Medical condition: Long-term Follow-up of prior study participants | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Prematurely Ended) ES (Completed) IT (Completed) NL (Prematurely Ended) PT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-012782-63 | Sponsor Protocol Number: P06086 | Start Date*: 2010-01-08 | ||||||||||||||||||||||||||
Sponsor Name:Schering-Plough Research Institution, A Division of Schering Corporation | ||||||||||||||||||||||||||||
Full Title: Boceprevir and Peginterferon/Ribavirin for the Treatment of Chronic Hepatitis C in Treatment-Naive Subjects: A Comparison of Erythropoietin Versus Ribavirin Dose Reduction for the Management of Anemia | ||||||||||||||||||||||||||||
Medical condition: Chronic Hepatitis C | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: FR (Completed) ES (Completed) DE (Completed) IT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-004556-71 | Sponsor Protocol Number: P05514 | Start Date*: 2009-05-25 | ||||||||||||||||||||||||||
Sponsor Name:Schering-Plough Research Institute, A Division of Schering Corporation | ||||||||||||||||||||||||||||
Full Title: Estudio de un solo grupo para facilitar tratamiento con boceprevir a sujetos con el genotipo 1 del virus de la hepatitis C crónica que no han respondido a peginterferón/ribavirina en estudios previ... | ||||||||||||||||||||||||||||
Medical condition: Hepatitis C Crónica | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: ES (Completed) FR (Completed) DE (Completed) BE (Completed) IT (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-004760-39 | Sponsor Protocol Number: P05685 | Start Date*: 2009-04-03 | ||||||||||||||||||||||||||
Sponsor Name:Schering Plough Research Institute, A Division of Schering Corporation | ||||||||||||||||||||||||||||
Full Title: A phase 3 safety and efficacy study of boceprevir in combination with peginterferon alfa-2a and ribavirin in subjects with chronic hepatitis C genotype 1 who failed prior treatment with peginterfer... | ||||||||||||||||||||||||||||
Medical condition: Chronic Hepatitis C | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) BE (Completed) IT (Completed) FR (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
